CN Stock MarketDetailed Quotes

003020 Hefei Lifeon Pharmaceutical

Watchlist
  • 18.76
  • +0.19+1.02%
Market Closed Dec 19 15:00 CST
3.59BMarket Cap20.62P/E (TTM)

Hefei Lifeon Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hefei Lifeon Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
355.78M
--
+38.59%
EPS
--
0.22
--
--
Analyst Rating
Strong Buy

Dec 19, 2024

Hefei Lifeon Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.833B--
--2024/FY-- / 1.551B--
Mar 30, 20242023/FY1.901B / 1.687B--
--2022/FY2.579B / 2.601B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.833B--
--2024/FY-- / 1.551B--
Mar 30, 20242023/FY1.901B / 1.687B--
--2022/FY2.579B / 2.601B--
--------

Unlock Free Earnings Estimates

Hefei Lifeon Pharmaceutical Earnings Reports

  • Cube Pharmaceuticals: Report for the third quarter of 2024

    Oct 29 12:00 ET

  • Cube Pharmaceuticals: 2024 Semi-Annual Report Summary

    Aug 30 12:00 ET

  • Cube Pharmaceuticals: Semi-Annual Report 2024

    Aug 30 12:00 ET

  • Hefei Lifeon Pharmaceutical: 2024 First Quarter Report

    Apr 29 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    YINOW ELECTRIC
    837046
    19.89 +30.00%
    SUGON DATA ENERGY
    872808
    67.38 +29.38%
    Dark Horse Technology Group
    300688
    40.90 +20.01%
    Shenzhen L&A Design
    300949
    48.82 +20.01%
    Shanghai Kaytune Industrial
    301001
    34.19 +20.01%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 19, 2024

    Strong Buy

    • Strong Buy

      71.43%

    • Buy

      28.57%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data